3billion receives accreditation from the College of American Pathologists
3billion has received CAP accreditation on November 15th. CAP accreditation is an evaluation system by the College of American Pathologists, an organization of clinical pathologists in…
3billion selected as a finalist of the Novartis Korea’s Health X-Challenge Seoul
On December 8th, 3billion was selected as a finalist of the Novartis Korea’s Health X-Challenge Seoul for the ‘Genetic retinal disease’ category. 3billion was highly…
3billion announces pathogenicity predictor '3Cnet'
3billion announces 3Cnet, a pathogenicity prediction tool based on recurrent neural networks.…
Immediate Diagnosis Through Collaboration with Dr. Alisdair McNeill
Immediate Diagnosis Through Collaboration with Dr. Alisdair McNeill “I was surprised that such a recent publication would be incorporated into clinical reporting so rapidly. It is…
3billion announces Dr. Hane Lee of UCLA as Chief Clinical Geneticist
3billion announces Dr. Hane Lee of UCLA as Chief Clinical Geneticist 3billion has announced Dr. Hane Lee, a former UCLA professor of pathology/diagnostic medicine and…
3billion looks to 2022 IPO, expansion into drug discovery
The Korean startup, having only been founded in October 2016, is already on track to go public in early 2022 on the KOSDAQ. The KOSDAQ and…
Rare disease screening firm 3Billion closes $13M Series C financing
Rare Disease Screening Firm 3Billion Closes $13M Series C Financing The Korean startup 3billion has officially closed its Series C funding by raising $13 million. They…
3billion aims for the global market by IPO
3billion Aims for the Global Market by IPO 3billion, an AI-based rare disease genetic diagnosis startup, aims for the global market by IPO. 3billion has selected…
3billlion named "Next Unicorn" at ASEAN-Korea
Korean Genetic Testing Firm 3billlion Named "Next Unicorn" at ASEAN-Korea Scale-up Contest 3billion wins the "Next Unicorn" award in the 'ASEAN-Korea Scale-up…
3billion CEO Changwon Keum: "We diagnose 7,000 rare diseases at once using AI"
3billion CEO Changwon Keum "We diagnose 7,000 rare diseases at once using AI" In an interview with Seoul Economic Daily, Changwon Keum, CEO…
Korean genetic testing firm makes genetic test for rare diseases affordable
Korean Genetic Testing Firm Makes Genetic Test for Rare Diseases Affordable3billion announces that for a service fee of $699, it can diagnose over 7,000 rare…
Korean rare disease diagnostics firm 3billion raises $10M
Korean Rare Disease Diagnostics Firm 3billion Raises $10M 3billion raises $10 million in a Series B financing round, led by Korea Development Bank. Other investors included…